Neeraj Panchal, DDS
Oral & Maxillofacial Surgery · Philadelphia, PANPI 1922237981
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $57,068 of the $73,183 with a category attached, or 78.0%. 9 manufacturers reported payments, led by Envista Holdings Corporation at 48.5% of the total. 2025 is the largest year on record at $33,277, more than ten times the $363 reported in 2019. Among oral & maxillofacial surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 70 payments — averaging $1045.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Envista Holdings Corporation$35K
- Medical Device Business Services, Inc.$34K
- Johnson & Johnson$2K
- Stryker$1K
- Nobel Biocare USA$654
- Kls-martin L.p.$167
- plus $84 from 3 others
What the payments were for
- Consulting fees$57,06878%
- Travel & lodging$13,23318%
- Food & beverage$2,7574%
- Education$1260%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Envista Holdings Corporation | 7 | $35,479 |
| Medical Device Business Services, Inc. | 22 | $34,148 |
| Johnson & Johnson | 15 | $1,607 |
| Stryker | 7 | $1,045 |
| Nobel Biocare USA | 15 | $654 |
| Kls-martin L.p. | 1 | $167 |
| Misonix Inc | 1 | $36 |
| Geistlich Pharma, North America, Inc. | 1 | $32 |
| Axogen | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EDUCATION$35,479
- TRUMATCH$34,362
- NA$1,018
- MATRIXMANDIBLE$396
- MATRIXCOMBO$263
- MATRIXMIDFACE$227
- MATRIXWAVE$117
- MATRIXORTHOGNATHIC$117
- MATRIXRIB$116
- NOBELACTIVE$106
- NOBELPARALLEL$106
- NOBELSPEEDY$106
- NOBELREPLACE$106
- NOBELPROCERA$106
How this compares
$73,183 in reported general payments places this provider in the 95th percentile of 369 oral & maxillofacial surgery providers in Pennsylvania.
See all oral & maxillofacial surgery providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 24 | $109 |
| Amoxicillin | 18 | $91 |
Paid to pharmacies, not to this prescriber.
Other oral & maxillofacial surgery in Philadelphia
- Eric GranquistPhiladelphia$65K
- Bradley HershPhiladelphia$20K
- Andrew YampolskyPhiladelphia$6K
- Allison RodriguezPhiladelphia$4K
- John MasiPhiladelphia$4K
- Justin BurnsPhiladelphia$3K
- Frank DorobaPhiladelphia$3K
- Lauren TragerPhiladelphia$3K
- Akshar YagnikPhiladelphia$3K
- Berfin KaratasPhiladelphia$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.